FINWIRES · TerminalLIVE
FINWIRES

週四交易中,美國存託憑證上漲,亞洲股票在美國交易。

By

-- 週四上午,亞洲股市在美國交易,美國存託憑證(ADR)小幅走高,標普亞洲50 ADR指數上漲0.36%,至2768.22點。 北亞方面,生物製藥公司再鼎醫藥(ZLAB)和太陽能板製造商晶科能源(JKS)領漲,分別上漲4.3%和4.1%。緊追在後的是金融科技公司樂信金融(LX)和科技公司迅雷(XNET),分別上漲2.5%和2.3%。 北亞方面,電動車製造商蔚來汽車(NIO)和半導體公司思創科技(SIMO)領跌,分別下跌3.7%和3.5%。緊隨其後的是網路和資料中心服務供應商VNET集團(VNET)和半導體公司海邁科技(HIMX),分別下跌2.1%和1.5%。 南亞股市領漲的股票包括IT公司Sify Technologies (SIFY)和電信業者PLDT (PHI),分別上漲0.7%和0.6%。緊隨其後的是IT公司Wipro (WIT)和貸款機構ICICI銀行(IBN),分別上漲0.5%和0.2%。 南亞股市跌幅居前的股票包括科技集團Sea (SE)和電信業者印尼電信(TLK),分別下跌0.4%和0.3%。緊隨其後的是製藥公司Dr. Reddy's Laboratories (RDY)和IT公司Infosys (INFY),分別下跌0.2%和0.1%。

Related Articles

Australia

Amazon's Backlog Ramp Points to Accelerating Revenue Growth, UBS Says

Amazon's (AMZN) backlog ramp, including $100 billion from Anthropic, points to accelerating revenue growth in 2026 and 2027, UBS said in a Thursday report."While there may still be some variability on the magnitude, the backlog ramp continues to point the way to accelerating revenue growth throughout 2026 and 2027, which should in turn raise investor confidence on ROIC," the note said. ROIC refers to return on invested capital.For 2026, the base case for Amazon Web Services growth is now 36%, the report said, adding that consolidated near-term revenue estimates have also moved up, driven by the e-commerce business following Q1 beat.UBS reiterated its buy rating and boosted its price target to $333 from $304.Price: $259.19, Change: $-3.85, Percent Change: -1.46%

$AMZN
Australia

Wells Fargo Adjusts Price Target on CoStar Group to $33 From $40

CoStar Group (CSGP) has an average rating of overweight and mean price target of $50.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $34.15, Change: $+0.01, Percent Change: +0.03%

$CSGP
Australia

Morgan Stanley Adjusts Price Target on AbbVie to $278 From $270

AbbVie (ABBV) has an average rating of overweight and mean price target of $253.15, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $213.21, Change: $+9.32, Percent Change: +4.57%

$ABBV